Columbia Biosciences is developing new technology to improve protein purification, custom antibody labeling and conjugation. Columbia began as a spin-off from Martek Biosciences Corporation in 2007 to accomplish three objectives and has a new proprietary method avoids unfolding and refolding of secondary antibodies. Columbia has developed new fluorescent products which allows us to make high-intensity streptavidin conjugates for use in fluorescent microscopy and High Throughput Screening (HTS).
Copyright 2011: Columbia Biosciences. Streptavidin Conjugates. All rights reserved.
6440 Dobbin Road, Suite D Columbia, MD 21045